News & Updates

Targeted therapy superior to chemotherapy, best supportive care at improving survival in NSCLC
Targeted therapy superior to chemotherapy, best supportive care at improving survival in NSCLC
09 Oct 2021

Survival benefit in patients with de novo stage IV nonsmall-cell lung cancer (NSCLC) depends on the type of treatment received, with significantly better median overall survival (OS) seen with the use of small-molecule targeted therapy against epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements than with best supportive care, reports a study.

Targeted therapy superior to chemotherapy, best supportive care at improving survival in NSCLC
09 Oct 2021
Acute pancreatitis on the rise worldwide
Acute pancreatitis on the rise worldwide
09 Oct 2021

Acute pancreatitis has seen a steady increase in worldwide incidence over the last five decades, particularly in Western countries, a recent study has found.

Acute pancreatitis on the rise worldwide
09 Oct 2021
CV risk remains elevated in metabolically healthy obese
CV risk remains elevated in metabolically healthy obese
08 Oct 2021 byRoshini Claire Anthony

Individuals who are obese but without metabolic abnormalities (metabolically healthy obese [MHO]) have an elevated risk of developing MACE-HF*, new-onset heart failure (HF), and new-onset atrial fibrillation (AF), according to a French study presented at EASD 2021.

CV risk remains elevated in metabolically healthy obese
08 Oct 2021
Ketone supplements may promote better brain health in obese adults
Ketone supplements may promote better brain health in obese adults
08 Oct 2021